使用Tubridge血流导向装置进行载瘤动脉重建治疗大型或巨大脑动脉瘤:多中心随机对照临床试验(PARAT)
PARAT试验是一项前瞻性多中心随机对照研究,在中国12家医院纳入未破裂大型或巨大颅内动脉瘤成人患者,1:1随机接受Enterprise支架辅助弹簧圈栓塞或Tubridge血流导向装置植入。6个月随访完全闭塞率Tubridge组为75.34%,支架辅助弹簧圈组为24.53%,共同比值比为9.4(95%CI 4.14-21.38;P<.001)。Tubridge组并发症发生率更高但无统计学显著性,研究点比较提示血流导向装置植入存在学习曲线。
要点
- 大型或巨大未破裂颅内动脉瘤6个月完全闭塞率Tubridge组75.34% vs 支架辅助弹簧圈组24.53%。
- 共同比值比9.4(95%CI 4.14-21.38;P<.001),支持Tubridge闭塞率更高。
- Tubridge组并发症频率更高但无统计学显著性。
核心结论
- Tubridge血流导向装置治疗大型和巨大动脉瘤的闭塞率明显高于Enterprise支架辅助弹簧圈栓塞,但闭塞率提高以并发症发生率无显著升高为代价;研究点比较提示应认识血流导向装置植入的学习曲线并纳入试验设计。
研究设计与样本
- 前瞻性、多中心、随机对照临床试验,在中国12家医院开展,纳入未破裂大型或巨大颅内动脉瘤成人患者,1:1随机分配至Enterprise支架辅助弹簧圈栓塞组或Tubridge血流导向装置植入组;主要终点为6个月随访完全闭塞,次要终点包括技术成功、死亡率、靶血管相关卒中、动脉瘤出血、支架内狭窄、载瘤动脉闭塞及所有不良事件频率;共185例入组,41例在手术开始前退出,82例接受Tubridge植入,62例主要接受支架辅助弹簧圈栓塞。
诊断标准与关键数值
- 主要终点6个月随访完全闭塞率:Tubridge组75.34% vs 支架辅助弹簧圈组24.53%,共同比值比9.4(95%CI 4.14-21.38;P<.001)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 185例入组受试者中41例在手术开始前退出。
- Tubridge组并发症频率更高但无统计学显著性。
- 多因素分析显示主要研究点卒中率降低,P值为边缘性(P=.051)。
- 研究点比较提示应认识血流导向装置植入的学习曲线并纳入试验设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Although flow diverters have been reported with favorable clinical and angiographic outcomes in various literatures, randomized trials determining their true effectiveness and safety are still in lack. The Parent Artery Reconstruction for Large or Giant Cerebral Aneurysms Using the Tubridge Flow Diverter (PARAT) trial was designed to evaluate the safety and efficacy of the Tubridge flow diverter in the treatment of large or giant aneurysms in comparison with Enterprise stent-assisted coiling.
MATERIALS AND METHODS: This prospective, multicenter, randomized trial was conducted at 12 hospitals throughout China. Enrolled adults with unruptured large/giant intracranial aneurysms were randomly assigned (1:1) to receive either Enterprise stent-assisted coiling or Tubridge flow diverter implantation. The primary end point was complete occlusion at 6-month follow-up, while secondary end points included technical success, mortality, target vessel-related stroke, aneurysm bleeding, in-stent stenosis, parent artery occlusion, and the frequency of all adverse events.
RESULTS: Among 185 enrolled subjects, 41 withdrew before procedure initiation. Overall, 82 subjects underwent Tubridge implantation, and 62 subjects were primarily treated with stent-assisted coiling. The results of 6-month follow-up imaging included complete occlusion rates of 75.34% versus 24.53% for the Tubridge and stent-assisted coiling groups, respectively, with a calculated common odds ratio of 9.4 (95% confidence interval, 4.14-21.38; P < .001). There was a higher, nonsignificant frequency of complications for Tubridge subjects. Multivariate analysis showed a decreased stroke rate at the primary investigational site, with a marginal P value (P = .051).
CONCLUSIONS: This trial showed an obviously higher rate of large and giant aneurysm obliteration with the Tubridge FD over Enterprise stent-assisted coiling. However, this higher obliteration rate came at the cost of a nonsignificantly higher rate of complications. Investigational site comparisons suggested that a learning curve for flow-diverter implantation should be recognized and factored into trial designs.
引用
- Liu JM, Zhou Y, Li Y, et al. Parent Artery Reconstruction for Large or Giant Cerebral Aneurysms Using the Tubridge Flow Diverter: A Multicenter, Randomized, Controlled Clinical Trial (PARAT). AJNR Am J Neuroradiol. 2018. PMID: 29599173. doi:10.3174/ajnr.A5619
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。